Aferdita Spahillari, MD, MPH; Jinyi Zhu, MPH; Bart S. Ferket, MD, PhD; et al.
free access
JAMA Cardiol. 2020;5(8):871-880. doi:10.1001/jamacardio.2020.1240
This economic evaluation creates a model of African American individuals at intermediate risk of atherosclerotic cardiovascular disease to estimate the cost-effectiveness of coronary artery calcium assessment in the decision to use statin therapy.
Kevin R. Bainey, MD, MSc; Thomas Engstrøm, DMSci, PhD; Pieter C. Smits, MD, PhD; et al.
free access
JAMA Cardiol. 2020;5(8):881-888. doi:10.1001/jamacardio.2020.1251
This meta-analysis of 10 randomized clinical trials assesses whether complete revascularization is associated with reduced cardiovascular mortality and whether heterogeneity is found in treatment outcomes when fractional flow reserve– and angiography-guided nonculprit lesion percutaneous coronary intervention strategies are performed.
Chase R. Brown, MD, MSHP; Zehang Chen, BA, BSN; Fabliha Khurshan, BS; et al.
free access
JAMA Cardiol. 2020;5(8):889-896. doi:10.1001/jamacardio.2020.1445
This cohort study examines the proportion of opioid-naive patients who develop persistent opioid use after cardiac surgery.
-
Invited Commentary
Slowing the Opioid Epidemic by Controlling a Source: Disabling the Pump
Steven A. Farmer, MD, PhD; Michelle Schreiber, MD; Keith A. Horvath, MD
JAMA Cardiol
Rita Hamad, MD, PhD; Joanne Penko, MS, MPH; Dhruv S. Kazi, MD, MSc, MS; et al.
free access
JAMA Cardiol. 2020;5(8):899-908. doi:10.1001/jamacardio.2020.1458
This study uses a computer simulation to estimate the excess burden of a cardiovascular event and its downstream and upstream risk factors among adults with a low socioeconomic status.
Kara N. Goss, MD; Kristin Haraldsdottir, PhD; Arij G. Beshish, PhD; et al.
free access
JAMA Cardiol. 2020;5(8):910-919. doi:10.1001/jamacardio.2020.1511
This cross-sectional cohort study characterizes cardiac structure and function in adolescents and young adults born preterm using cardiac magnetic resonance imaging.
Trisha Singh, BM; Rong Bing, MBBS; Marc R. Dweck, MD, PhD; et al.
free access
JAMA Cardiol. 2020;5(8):920-928. doi:10.1001/jamacardio.2020.1567
This post hoc analysis of the Scottish Computed Tomography of the Heart (SCOT-HEART) open-label randomized clinical trial in patients with suspected angina secondary to coronary heart disease evaluates the utility of exercise electrocardiography in contemporary practice and assesses the value of combined functional and anatomical testing.
Tamiel N. Turley, BS; Megan M. O’Byrne, MA; Matthew L. Kosel, BS; et al.
free access
JAMA Cardiol. 2020;5(8):929-938. doi:10.1001/jamacardio.2020.0872
This genetic association study evaluates common single-nucleotide variations associated with spontaneous coronary artery dissection susceptibility.
Roxana Mehran, MD; Jaya Chandrasekhar, MBBS, MS; Philip Urban, MD; et al.
free access
JAMA Cardiol. 2020;5(8):939-947. doi:10.1001/jamacardio.2020.0285
This prespecified secondary analysis of a randomized clinical trial examines the variables contributing to the incidences of major or minor and vascular or nonvascular bleeding after percutaneous coronary intervention (bare metal stent or polymer-free, biolimus A9-eluting drug-coated stent) and dual antiplatelet therapy in women and men at an increased risk for bleeding.